Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Sunday, September 27

1:30 PM - 1:40 PM ET

6 - Evaluation of PAM50 Molecular Subtypes in Post-Prostatectomy Salvage Radiotherapy: An NRG Oncology-RTOG 0534 Analysis
Speaker: Zhao, Shuang, MD, MSE - UT MD Anderson Cancer Center, Houston, TX
1:40 PM - 1:50 PM ET

7 - Five-Year Results of a Phase 3 Trial of Hypofractionated vs. Conventional Postprostatectomy Radiotherapy: NRG Oncology GU003
Speaker: Buyyounouski, Mark, MD, MS, FASTRO - Stanford University, Stanford, CA
1:50 PM - 2:00 PM ET

Discussant
Speaker: Kamran, Sophia, MD - Massachusetts General Hospital, Boston, MA
2:00 PM - 2:10 PM ET

10 - Phase II Multi-Institutional Study of Ultralow-Dose (4Gy) Response-Adapted Radiotherapy for Symptomatic Bone Metastases from Multiple Myeloma
Speaker: Ballas, Leslie, MD, FASTRO - Cedars Sinai, Los Angeles, CA
2:10 PM - 2:20 PM ET

11 - Stereotactic Body Radiation Therapy (SBRT) and Comprehensive Metastasis-Directed Therapy for Ewing Sarcoma Patients Enrolled on AEWS1221: A Report from the Children's Oncology Group (COG)
Speaker: Laack, Nadia, MD, MS - Mayo Clinic, Rochester, MN
2:20 PM - 2:30 PM ET

4 - Randomized Trial of Low-Dose Radiotherapy for Knee Osteoarthritis: Patient-Reported, Structural and Long-Term Clinical Endpoints
Speaker: Koneru, Nagendra (Bobby), MD, FASTRO - FHN Memorial Hospital, Freeport, IL
2:30 PM - 2:40 PM ET

LBA 03 - SWOG S1827/MAVERICK: A Randomized Phase III Trial of Brain MRI Surveillance with and without Prophylactic Cranial Irradiation (PCI) for Small-Cell Lung Cancer (SCLC)
Speaker: Brown, Paul, MD - Mayo Clinic, Rochester, MN
2:40 PM - 2:50 PM ET

9 - Six-Year Overall Survival of Nivolumab Following Stereotactic Ablative Radiotherapy in Early-Stage Non-Small Cell Lung Cancer: Randomized I-SABR Trial
Speaker: Chang, Joe, MD, PhD, MS, FASTRO - MD Anderson Cancer Center, Houston, TX
2:50 PM - 3:00 PM ET

Discussant
Speaker: Slotman, Ben, MD, PhD, FASTRO - VU University Medical Center, Amsterdam, NH
3:00 PM - 3:10 PM ET

100 - Multimodal Modeling of Detailed Cancer Subtypes and Molecular Features from >60,000 Patients with Co-Registered H&E Images and Clinical Tumor Sequencing
Speaker: Boehm, Kevin, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
3:00 PM - 3:10 PM ET

107 - Co-Primary Endpoint Analysis for the INTREPId Randomized Trial of Prostate Radiation Therapy with Androgen Deprivation Therapy vs. Darolutamide Monotherapy
Speaker: King, Martin, MD, PhD - Brigham and Women's Hospital, Boston, MA
3:00 PM - 3:10 PM ET

110 - Pooled Analysis of Prospective Trials of FMISO PET-Guided 30Gy De-Escalation in HPV-Positive Oropharyngeal Cancer
Speaker: Lee, Nancy, MD, FASTRO - Memorial Sloan Kettering Cancer Center, New York, NY